Vitamed is a generic pharmaceutical manufacturer and part of Rekah Pharmaceutical Industries. Vitamed is working to increase its international presence by focusing on out-licensing, in-licensing, establishing new partnerships, and executing mergers and acquisitions.
Rekah Group is active at all levels of the value chain: production, R&D, marketing, sales, distribution, import, and export. The portfolio, which includes a wide range of 280 generic prescription and over-the-counter drugs, dermo-cosmetics, vitamins, and nutritional supplements, focuses on four core fields: steroids, antibiotics, ophthalmic medications, and over-the-counter drugs. The group operates research and development laboratories at its production sites in Holon and Binyamina.
Cumulative Funding Raised Over Time ($)
Employees Over Time
Vitamed, Rekah Group Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Sep 9, 2025
sg.finance.yahoo.com
Nifty clocks fifth session of gains led by IT on Infosys buyback, US rate cut hopes
undefined
Sep 9, 2025
finance.yahoo.com
Nikkiso Addresses Growing Ammonia-Handling Demand and Launches Next-Generation Pump at Gastech 2025
#Product Stage
Sep 9, 2025
www.hotelmanagement-network.com
Westin Desaru Coast Resort partners with CAYIN Technology for digital signage
#Partners
Sep 9, 2025
finance.yahoo.com
BHP Xplor Opens Applications for 2026 Cohort, Offering Equity-Free Funding and Global Support
#Partners
Sep 9, 2025
finance.yahoo.com
Assessing the Valuation of Yue Yuen Industrial (SEHK:551) After Recent Volatility